Quanterix narrows 2026 revenue outlook to $142M-$146M as Florida Medicaid sets $484 LucentAD reimbursement
At a glance
- $QTRX today+1.06%last $2.87
- Vs industry peers+1.46 pts6-peer median −0.40% · ahead
- Since Nov 9−5.90%from the first trade after the story
- 52-week range33.5% above low$2.15 – $8.77
- Cash runway~8 mo$35.9M cash ÷ $4.4M/mo burn · 10-Q
- In the headline$142 millionAmount
Nothing reported about quanterix across key-person, legal, regulatory, security, operational or financial-integrity risk in three weeks of coverage and 30 days of SEC filings.
Ranges are one standard deviation of volatility around the latest close — about 1 week in 3 moves further. Not a forecast or investment advice.
What it means
- What to watch: That $484 reimbursement rate is a key data point — how does it stack up against previous deals in the same category?
- How the stock is trading: $QTRX +1.06% in the latest session.
- Timing: It came out during market hours, so traders could react the same day, and the session move may reflect that.
Where the stock stands
Quanterix ($QTRX) added 1.06% to $2.87 in the latest session. Over the past month it is up 3.6%. It now sits 67% under the 52-week high of $8.77 and 33% above the year's low of $2.15. The year's high was 4.1 times its low, which makes double-digit swings fairly routine here.
What the filings say
In its latest report (10-Q, filed Nov 9, 2026), $QTRX lost $21.6M over the quarter to Sep 30, 2026 on revenue of $35.0M (+6.3% QoQ). Operations used $39.4M of cash over the nine months to Sep 30, 2026 — about $4.4M a month — against $35.9M in cash on Sep 30, 2026. At that pace the cash covers about 8 months, which is why financing, asset sales or restructuring tend to come up for companies in this position. Total liabilities were $81.1M against $35.9M of cash on Sep 30, 2026. The company filed an 8-K — the form for material events — on Nov 9, the same day as this story; it is $QTRX's own account and the first thing to read. Figures are as filed with the SEC; the $QTRX page has the full statements.
How much coverage it is getting
This is the only story on Quanterix in Wook's last 30 days of coverage, so there is no recent run to compare it with.
The bigger picture
Earnings reports are less about the numbers and more about how they align with expectations and what they signal for the future. Health Care reads calm on Wook's supply-chain scanner today, with no unusual stress in the filings and disclosures it watches.
What to watch next
The $QTRX page has all the charts, filings, and models. Checking another outlet can help confirm or spot repetition. Wook AI can pull live data and run the numbers on request.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on November 9, 2026. $QTRX has moved -5.90% ($3.05 to $2.87). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.
